These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25241927)

  • 21. Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P
    Stoit AR; Lange JHM; Coolen HKAC; Rensink A; van den Hoogenband A; den Hartog AP; van Schaik S; Kruse CG
    Bioorg Med Chem Lett; 2018 Feb; 28(3):459-465. PubMed ID: 29254642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists.
    Colandrea VJ; Legiec IE; Huo P; Yan L; Hale JJ; Mills SG; Bergstrom J; Card D; Chebret G; Hajdu R; Keohane CA; Milligan JA; Rosenbach MJ; Shei GJ; Mandala SM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2905-8. PubMed ID: 16580205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias.
    Tsukada YT; Sanna MG; Rosen H; Gottlieb RA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):660-9. PubMed ID: 18091583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
    Gilmore JL; Sheppeck JE; Watterson SH; Haque L; Mukhopadhyay P; Tebben AJ; Galella MA; Shen DR; Yarde M; Cvijic ME; Borowski V; Gillooly K; Taylor T; McIntyre KW; Warrack B; Levesque PC; Li JP; Cornelius G; D'Arienzo C; Marino A; Balimane P; Salter-Cid L; Barrish JC; Pitts WJ; Carter PH; Xie J; Dyckman AJ
    J Med Chem; 2016 Jul; 59(13):6248-64. PubMed ID: 27309907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Komiya T; Hagiya H; Mizuno H; Shioya H; Ono T; Takada Y; Maeda T; Matsunaga N; Kondo T; Tominaga S; Nunoya KI; Kiyoshi H; Komeno M; Nakade S; Habashita H
    J Med Chem; 2017 Dec; 60(23):9508-9530. PubMed ID: 29120624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
    Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
    Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists.
    Evindar G; Bernier SG; Doyle E; Kavarana MJ; Satz AL; Lorusso J; Blanchette HS; Saha AK; Hannig G; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2520-4. PubMed ID: 20304639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
    Hale JJ; Lynch CL; Neway W; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Parent SA; Chrebet G; Bergstrom J; Card D; Ferrer M; Hodder P; Strulovici B; Rosen H; Mandala S
    J Med Chem; 2004 Dec; 47(27):6662-5. PubMed ID: 15615513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors.
    Xu J; Wei L; Mathvink RJ; Edmondson SD; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5373-7. PubMed ID: 16919457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.
    Nakamura T; Asano M; Sekiguchi Y; Mizuno Y; Tamaki K; Nara F; Kawase Y; Yabe Y; Nakai D; Kamiyama E; Urasaki-Kaneno Y; Shimozato T; Doi-Komuro H; Kagari T; Tomisato W; Inoue R; Nagasaki M; Yuita H; Oguchi-Oshima K; Kaneko R; Nishi T
    Eur J Med Chem; 2012 May; 51():92-8. PubMed ID: 22405291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
    Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
    J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of S1P agonists with a dihydronaphthalene scaffold.
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Takada Y; Shioya H; Komiya T; Mizuno H; Ono T; Hagiya H; Minami M; Nakade S; Habashita H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3885-9. PubMed ID: 21641216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
    Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
    J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off the shelf but not mass produced.
    Karliner JS
    Chem Biol; 2005 Jun; 12(6):614-5. PubMed ID: 15975506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity.
    Lankau HJ; Unverferth K; Grunwald C; Hartenhauer H; Heinecke K; Bernöster K; Dost R; Egerland U; Rundfeldt C
    Eur J Med Chem; 2007 Jun; 42(6):873-9. PubMed ID: 17303289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration.
    Yamamoto R; Aoki T; Koseki H; Fukuda M; Hirose J; Tsuji K; Takizawa K; Nakamura S; Miyata H; Hamakawa N; Kasuya H; Nozaki K; Hirayama Y; Aramori I; Narumiya S
    Br J Pharmacol; 2017 Jul; 174(13):2085-2101. PubMed ID: 28409823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
    Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist.
    Feng DD; Biftu T; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Strader CD; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1427-9. PubMed ID: 10888324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.